clinical trial · NCT02510560
Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
Premature Birth of NewbornIntestinal MalabsorptionNTRA-2112Placebo
brief summary
The study will evaluate the effect of NTRA-2112 on intestinal malabsorption in preterm infants.
started
Oct 9, 2016
primary completion
Apr 25, 2018
completion
Apr 25, 2018
last updated
Aug 19, 2025
detailed description
The study will assess the efficacy and safety of NTRA-2112 on intestinal malabsorption in preterm infants as compared to placebo
official title
A Multi-center, Double-blind, Randomized, Three-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol